Vanda Pharmaceuticals Inc.

Historical 13F Holders

Symbol
VNDA
CUSIP
921659108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 921659108 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 8.1% 2/7/2025
Event 1/31/2025
Millennium Management LLC 13G/A
7.0% 10/9/2026
Event 9/30/2026
AQR Capital Management, LLC 13G
5.8% 8/13/2026
Event 6/30/2026
State Street Corp 13G 5.1% 5/12/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
BlackRock Portfolio Management LLC 13G/A 4.2% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 12.1 k $59.4 k
2026 Q2 177 49.7 M $305 M
2026 Q1 176 46.2 M $319 M
2025 Q4 166 42.0 M $370 M
2025 Q3 159 45.1 M $226 M
2025 Q2 149 45.2 M $213 M
2025 Q1 156 44.0 M $202 M
2024 Q4 156 43.3 M $209 M
2024 Q3 162 44.1 M $207 M
2024 Q2 160 45.8 M $259 M
2024 Q1 153 51.7 M $213 M
2023 Q4 165 54.4 M $229 M
2023 Q3 186 52.6 M $227 M
2023 Q2 194 56.2 M $371 M
2023 Q1 184 58.4 M $397 M
2022 Q4 198 59.3 M $438 M
2022 Q3 185 55.2 M $545 M
2022 Q2 182 56.0 M $611 M
2022 Q1 198 56.3 M $637 M
2021 Q4 220 54.5 M $854 M
2021 Q3 194 55.2 M $947 M
2021 Q2 192 54.9 M $1.18 B
2021 Q1 196 54.6 M $820 M
2020 Q4 189 56.7 M $745 M
2020 Q3 175 54.4 M $526 M
2020 Q2 175 55.2 M $631 M
2020 Q1 171 54.2 M $563 M
2019 Q4 192 53.6 M $880 M
2019 Q3 177 53.5 M $711 M
2019 Q2 179 59.7 M $841 M
2019 Q1 190 54.4 M $1.00 B
2018 Q4 203 53.6 M $1.40 B
2018 Q3 178 54.0 M $1.24 B
2018 Q2 143 49.1 M $936 M
2018 Q1 143 48.3 M $813 M
2017 Q4 138 40.9 M $621 M
2017 Q3 150 39.7 M $711 M
2017 Q2 141 38.9 M $633 M
2017 Q1 145 41.3 M $578 M
2016 Q4 158 42.4 M $677 M
2016 Q3 159 40.8 M $678 M
2016 Q2 130 38.8 M $434 M
2016 Q1 126 41.3 M $345 M
2015 Q4 131 42.6 M $397 M
2015 Q3 133 42.8 M $486 M
2015 Q2 122 42.4 M $538 M
2015 Q1 125 46.4 M $431 M
2014 Q4 125 47.7 M $682 M
2014 Q3 117 41.4 M $429 M
2014 Q2 127 39.1 M $633 M
2014 Q1 126 38.4 M $624 M